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Abstract
This case report describes two significant long-term complications experi-
enced by a patient following treatment for pellucid marginal degeneration 
(PMD). Two years after undergoing a combination of topography-guided 
photorefractive keratectomy (T-PRK) and corneal collagen cross-linking 
(CXL) procedures, the patient continued to experience glare and dryness 
associated with persistent stromal haze and dry eye. These procedures re-
sulted in dissatisfaction with the final outcome, which led the patient to 
seek contact lens correction. Management of the symptomatic ocular se-
quelae with specialty soft toric contact lenses designed for irregular cor-
neas supported her visual rehabilitation. 
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Pellucid marginal degeneration (PMD) is a progressive non-inflammatory ectatic disorder involving the in-ferior peripheral region of the cornea.1–3 In this disorder, thinning occurs in a crescent shape extending from the 4 o’clock to 8 o’clock position in the peripheral cornea. While the amount of irregular astigmatism 
depends on the severity of the condition, the vision distortion secondary to PMD is typically asymptomatic in 
the early stages because the area of thinning does not involve the visual axis. For this reason, corneal topogra-
phy is the gold standard for diagnosis of this condition.3 The current standard of practice in the management 
of PMD includes spectacles, contact lenses and surgical interventions, such as lamellar or penetrating kerato-
plasty.1,4,5 Recently, simultaneous topography-guided photorefractive keratectomy (T-PRK) and corneal collagen 
cross-linking (CXL) procedures have been used to manage PMD and other causes of keratoectasia with the aim 
of slowing the progression, minimizing corneal irregularity, and reducing the need for a corneal transplant. 6–10
T-PRK involves ablation of the corneal stromal tissue by an excimer laser with customization based on wave-
front aberrometry, tomography, and topography.11–13 By flattening the corneal apex or elevated and steepened 
tissue adjacent to ectatic areas, this procedure normalizes the cornea by reducing the astigmatism and irregu-
larity of the corneal surface.6,11,13 CXL uses the photosensitization of riboflavin with ultraviolet A (UVA) light to 
induce the polymerization of collagen fibers in the anterior 200 to 300 microns of the corneal stroma.14–18 CXL 
effectively increases the corneal rigidity and the biomechanical strength by three-fold.8,17,19 CXL also results in 
simultaneous flattening of the steepest area and steepening of adjacent areas around the cone, which decreases 
corneal asymmetry and spherical aberration.19 The combination of these procedures, with CXL performed 
immediately after T-PRK, is beneficial in the management of corneal ectasia.8–10 It has been demonstrated 
that the operating time can be reduced if these procedures are performed simultaneously.20 This also allows 
for riboflavin to reach and induce collagen cross-linking in the deeper layers of stromal tissue.20 It minimizes 
the potential for superficial stromal scarring resulting from PRK by diminishing fibroblast activity after the 
eradication of keratocytes.6 Reversing the order of these two procedures would result in either the removal 
of stiffened cross-linked corneal tissue or a reduction in the ablation rate of cross-linked tissue with altered 
biomechanical properties, neither of which would be beneficial.8,10,20
The effectiveness of simultaneous T-PRK and CXL in halting the progression of ectasia over a limited period of time 
and improving uncorrected and best-corrected visual acuities for PMD has been well documented.8,10 However, 
little information is available regarding the complications from these procedures. This case report describes two 
such complications (permanent corneal stromal haze and dry eye) and their management. 
CASE REPORT
A 41-year-old Caucasian female presented at the University of Waterloo School of Optometry and Vision Science 
Contact Lens Clinic for a consultation regarding specialty contact lens options. Her chief visual concerns included 
significant light sensitivity and glare, both of which were severe enough to have impacted her daily activities. Her 
ocular history was significant for bilateral PMD that had been diagnosed five years previously at a refractive sur-
gery consultation appointment in 2010. Shortly after her diagnosis, she underwent simultaneous T-PRK and CXL 
in both eyes. The patient attributed her debilitating visual symptoms and dry eye to these procedures. Overall, her 
general heath was unremarkable other than the occasional migraine. A previous medical examination had ruled out 
Sjogren’s syndrome. Her current medications included cyclosporine (Restasis®), duloxetine (Cymbalta®), lorazepam, 
and zopiclone (Imovane®).
Other significant ocular and contact lens history included prior experience with gas permeable and disposable soft 
lenses, with little success primarily due to her severe symptoms of dryness, which eventually led to contact lens 
intolerance. She had previously been prescribed a series of standard dry eye managements, including lid hygiene 
and hot compresses, frequent application of artificial tears with and without lipid components, a one-month course 
of topical loteprednol, a two-year course of topical cyclosporine A and bilateral inferior punctal occlusion. None of 
these prior therapies had restored the patient’s visual comfort to a level that allowed her to perform daily functions. 
Upon ocular examination, refraction was -0.75/-2.50 x 148(6/9-2) in her right eye and -0.25/-2.25 x 057 (6/9+2) in her 
left eye. All entrance tests were unremarkable. Her pupils were equal in size at approximately 8.0mm under scoto-
pic conditions and 5.0mm under photopic conditions. 
Biomicroscopic examination of the anterior segment revealed central stromal haze in both eyes with signifi-
cant confluent staining of the epithelium of the inferior cornea, which was graded at 2+. Bilateral central stro-
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mal haze was also observed using an anterior segment optical coherence tomography (OCT) imaging system 
(Visante™, Zeiss, Jena, Germany) (Figure 1A shows the right eye and Figure 1B shows the left eye). Further-
more, the demarcation line as a result of the CXL procedure could be observed and the corneal haze extended 
through the anterior and posterior stroma. Mild to moderate meibomian gland dysfunction was noted in both 
eyes. Tear breakup times (TBUT) were 4 seconds and 5 seconds in the right and left eyes, respectively. A phe-
nol red thread test (PRTT) gave results of 22mm in the right eye and 18mm in the left eye, which ruled out 
aqueous-deficient dry eye. 
 
Figure 1A Figure 1B
Corneal topographies obtained with a Pentacam™ system (Oculus, Wetzlar, Germany) revealed simulated keratom-
etry values of 38.4D@168°/ 40.0D in the right eye and 38.8D@67.5°/ 39.6D in the left eye (Figure 2).  
Figure 2A
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Figure 2B
According to her prior medical records at the refractive surgery consultation, her baseline simulated keratometry 
readings were 43.00D@097°/ 45.00 in the right eye and 45.00D@015°/ 46.00 in the left eye. Pachymetry results 
revealed a thinnest-point reading of 564µm in the right eye and a thinnest-point reading ranging from 247 µm to 
555µm with large variability across multiple scans in the left eye. Mild-to-moderate meibomian gland dysfunction 
without corneal abnormalities was noted on an anterior segment health check. 
We concluded that the patient exhibited visual symptoms secondary to corneal haze as a result of having under-
gone T-PRK and CXL, as well as evaporative dry eye symptoms that worsened following the procedure. After 
extensive discussions with the patient on management options, we decided that she might benefit from specialty 
contact lenses. The initial specialty contact lens option considered for this patient was scleral lenses. In anticipa-
tion of easier adaptation, we chose a scleral lens with a smaller overall diameter and a thinner center thickness. 
According to the Rose K2 XL™ (Blanchard Laboratories, Sherbrooke, Quebec) fitting guide21, we selected the 
following diagnostic lenses: 
OD: Rose K2 XL / 8.00/ 14.6/ plano/ Standard periphery
OS: Rose K2 XL / 8.10/ 14.6/ plano/ Standard periphery
The lenses were applied and a settling time of 30min was allowed. The lens fitting characteristics were then 
examined. Both lenses demonstrated excessive clearance centrally and minimal clearance limbally. The lenses 
were well-centered and provided good coverage. Mild edge lift was noted in both eyes at 3 and 9 o’clock . The 
patient also reported mild-moderate lens awareness in both eyes. The fit of the lenses was deemed to be too 
steep centrally. Based on the assessment and over-refraction of the trial lenses, we placed a final order with the 
following parameters:  
OD: Rose K2 XL / 8.00/ 14.8/ -4.00/ Decreased edge lift #1
OS: Rose K2 XL / 8.30/ 14.8/ -2.75/ Decreased edge lift #1
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Follow-up #1
At the lens delivery appointment, the fit of the lenses was deemed appropriate, with adequate central clearance. 
The patient continued to report mild-moderate lens awareness. She was counselled that initial lens awareness is 
appropriate for a novice scleral lens wearer, and informed to slowly increase wear time to ease the adaptation pro-
cess, beginning with two to three hours daily until her next follow-up appointment. She was also instructed how to 
properly insert and remove the scleral lenses along with proper handling techniques. The lenses were dispensed to 
the patient along with a starter kit of Daily Boston Simplus ® solution (Bausch and Lomb, Rochester, NY). 
Follow-up #2
At the two-week follow-up appointment, lens assessment using a biomicroscope confirmed that the lenses were 
well centered with an appropriate apical clearance of approximately 75 microns in accordance with the Rose K2 
XL fitting manual.21 Mild, but tolerable, compression in the limbal zone was noted superiorly and inferiorly in both 
eyes. The spherocylindrical over-refraction was +1.00-2.00x105 (6/7.5) in the right eye and +0.25-1.00x090 (6/7.5-3) 
in the left eye. However, while the patient reported a reduction in her symptoms of dryness with lens wear, she was 
dissatisfied with the general comfort of the contact lenses, and noted greater lens awareness in the left eye com-
pared to the right eye. Ultimately, we concluded that the patient should discontinue the use of scleral lenses due to 
inadequate comfort and poor adaptation to this type of lens. 
The patient was refitted with Kerasoft® IC (Bausch + Lomb), a custom soft keratoconic lens design, as an alternative 
for the management of her visual symptoms. We ordered lenses with the following parameters: 
OD: Kerasoft® IC / 8.20/ 14.5/ -0.50 -0.75 x 052 / Flat #1 periphery
OS: Kerasoft® IC / 8.60/ 14.5/ -1.25 -1.00 x 075/ Standard periphery
Follow-up #3
At the two-week follow-up appointment for the Kerasoft® IC lenses, the patient was quite content and reported 
a subjective improvement in the quality of her vision with lens wear and no eye fatigue. She reported good 
overall comfort with the lenses. However, she was only able to wear her lenses for two hours per day, after 
which her vision became foggy. She was using Biotrue™ multipurpose solution (Bausch + Lomb) to clean and 
store the lenses on a nightly basis. The patient achieved visual acuities of 6/7.5 in the right eye and 6/9+ in the 
left eye with no significant improvement in vision with a spherical over-refraction. In a lens assessment, both 
lenses were observed to be well centered with adequate movement on primary gaze and upgaze. The rotation 
was stable at 5 degrees counter-clockwise in the right eye and 12 degrees counter-clockwise in the left eye. A 
moderate amount of lipid deposits was found on her lenses. At the end of the appointment, we decided that she 
should continue with her lenses with no changes in the parameters, but to switch her care system to Peroxi-
clear™ (Bausch + Lomb). Complete Blink and Clean™ eye drops (Abbott Medical Optics, Abbott Park, IL) were 
recommended as needed during contact lens wear. 
Follow-up #4
The patient reported good results with Kerasoft® IC lenses. Her wear time had increased to seven hours per day for 
three to four days per week with the change in her care system and the use of Complete Blink and Clean™ eye drops 
(Abbott Medical Optics) four times daily. The patient continued to experience subjective glare with the lenses, 
likely as a result of her large pupil size in photopic and scotopic conditions and the significant corneal haze second-
ary to the simultaneous T-PRK and CXL procedures. The custom soft keratoconic lenses successfully restored her 
functional vision for normal daily activities. She will be followed-up quarterly.  
DISCUSSION
Pellucid marginal degeneration (PMD) is a progressive non-inflammatory keratoectasia resulting in inferior 
corneal thinning and irregular astigmatism.1–3 The use of gas permeable corneal and scleral contact lenses can 
correct the irregular astigmatism that is induced as the condition progresses and the cornea thins. It has been 
shown that simultaneous T-PRK and CXL can increase the effectiveness of CXL by allowing better penetra-
tion of the riboflavin solution used with CXL, due to the absence of Bowman’s layer and a partially ablated 
stroma.20 The use of simultaneous procedures may also reduce the sub-epithelial haze that commonly follows 
PRK.6 The combined T-PRK and CXL technique can be an effective option for the management of PMD and 
can improve the prognosis by reducing the amount and irregularity of the corneal astigmatism. However, little 
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information is available regarding complications and patient satisfaction following the procedure. This case 
study presented a 41-year-old female patient who exhibited clinically significant permanent corneal haze and 
dry eye symptoms after undergoing combined T-PRK and CXL.
Permanent corneal haze following CXL is defined as a stromal opacity that persists for more than six months post-
CXL, and has been documented in 5% to 8.6% of cases.22,23 The corneal opacity that follows CXL typically spans 
the anterior 300 microns of stroma and can be differentiated from the sequelae post-PRK because the latter is 
sub-epithelial and much shallower.15,18,24,25 Furthermore, this long-term CXL complication is differentiated from the 
transient lacunar honeycomb-like central opacity that occurs within the anterior 300 microns of the corneal stroma 
present in all eyes at 1-month post-CXL.26,27 The presence of a transient haze, which only extends throughout the 
depth of the corneal stroma affected by CXL, is an expected indication of a successful CXL procedure. With the use 
of topical preservative-free steroid therapy, which is typically prescribed for 1 to 3 months postoperatively, the de-
crease in corneal transparency subsides over 6 months to 1 year following CXL, and coincides with the completion 
of keratocyte repopulation.22,27 On the other hand, a permanent stromal haze reflects changes in crystalline proteins 
and lamellar interconnections induced by the interaction of riboflavin and ultraviolet A radiation.28,29 While this 
steroid-resistant haze has not been shown to cause any reduction in high-contrast visual acuity, it may increase 
the backscatter of light that is internally reflected within the cornea.22,29–31 Thus, it may have led to the degradation 
of visual quality and the debilitating symptoms of glare and visual distortion due to these aberrations experienced 
by the patient in this case. Raiskup et al. noted a higher risk of permanent stromal haze following CXL in cases of 
severe keratoectasia with steeper pre-operative keratometric values.23 These cases likely presented with intrinsic 
stromal anomalies associated with keratoectasia, such as micro-striae and hyper-activated keratocyte nuclei in the 
stromal tissue, and with the presence of Vogt’s striae prior to the CXL procedure.23 
Regarding possible treatments, no studies to date have investigated the potential benefits of reducing the post-CXL 
stromal haze with the use of mitomycin C, an anti-proliferative agent that has been shown to reduce the risk of 
post-PRK corneal haze.32 However, the use of mitomycin C in patients with keratoectasia may be potentially contra-
indicated due to the cytotoxic properties of mitomycin C, and the role it plays in inducing keratocyte apoptosis may 
increase the risk of accelerating further corneal thinning. 
Our patient exhibited significant corneal haze that spanned the full stromal thickness in both eyes, as demonstrated in 
the anterior segment OCT scans in Figure 1. The scans also demonstrate a demarcation line through the stroma that 
signifies the extent of anterior stroma that had been affected by CXL.15,18,25-27,30,33 This presentation of stromal opacity 
that extends into the posterior stroma is atypical of post-CXL stromal haze. Güell et al. reported posterior stromal haze 
developing 5 months after simultaneous T-PRK and CXL in a 22-year-old patient with forme fruste keratoconus.34 In 
another case series, linear hyper-reflective structures were noted in 13 of 28 eyes that had undergone simultaneous T-
PRK and CXL for the management of keratoconus.35 However, the authors did not find any correlation between the 
prevalence of posterior stromal haze and the patient’s preoperative corneal thickness or ablation depth. 
 Dryness after kerato-refractive surgery is one of the primary causes of patient post-operative dissatisfaction.36 In-
terruption of the neural feedback system due to a reduction in corneal sensitivity has been proposed to be the pri-
mary cause of dry eye after kerato-refractive surgery.37,38 In the case of combined T-PRK and CXL, the epithelium 
is removed using either topical alcohol, mechanical scraping, a rotating brush, or a laser, followed by irradiation of 
the anterior 300 microns of stromal tissue with UVA.20,39,40  This procedure leads to disruption of the sub-epithelial 
and anterior-mid stromal nerve plexus, resulting in transiently reduced lacrimal gland production within the first 
six months post-operatively.29,38,39 Regeneration of the sub-epithelial plexus from the surrounding non-irritated area 
begins at the end of the first month, while extension of the deeper stromal nerve plexus into the anterior stroma can 
be observed as early as the second to third month.29 With the use of confocal microscopy, studies have confirmed 
that the number of nerve fibres is essentially restored to preoperative baseline values by six months after the proce-
dure, but the interconnections between neural fibres continue to increase up until two years after the procedure.29,41 
Corneal sensitivity returns to its preoperative baseline within one year after the procedure, and basic tear secretion 
and tear film stability should be restored concurrently. 29,42,43 
In this patient, PRTT of greater than 15mm was measured in both eyes along with a decreased TBUT, which suggested 
the presence of other factors that may have contributed to the signs and symptoms of dryness. Firstly, the cornea 
takes on an oblate topography after undergoing kerato-refractive surgery. The irregularity of the corneal surface, as 
confirmed by the presence of an oblique corneal cylinder, may act as an obstacle for the even distribution of the tear 
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film with blinking. Secondly, the discrepancy between reported symptoms and signs of dryness can be explained by 
an altered excitability in regenerated nerves caused by the induced inflammatory process after corneal nerve injury.44 
Thirdly, the long-term use of antidepressant and antianxiety medications has been known to have an anti-cholinergic 
effect, which results in decreased aqueous production and dry eye symptoms.45,46 Finally, a natural decrease in goblet 
cell population with age can contribute to a compromised mucin layer that results in the instability of the tear film.39,47
In this case study, a 41-year-old patient underwent simultaneous T-PRK and CXL shortly after a diagnosis of PMD. 
For a patient who was visually asymptomatic prior to her diagnosis, her quality of life is arguably decreased post-
operatively due to her debilitating symptoms of glare, light sensitivity, and dryness. Bilateral and permanent post-
CXL corneal haze and the resultant increase in internal reflectivity (light scatter) within the stromal tissue are 
responsible for her visual symptoms. These symptoms are likely exacerbated by her larger-than-average scotopic 
and photopic pupil sizes of 8mm and 5mm, respectively. The T-PRK and CXL procedures exacerbated her dry eye 
symptoms; she was already at high risk given her age, a pre-operative history of meibomian gland dysfunction and 
the use of an oral contraceptive, and her current use of antidepressant and anti-anxiety medications. While this 
patient is now being successfully managed with specialty soft toric lenses for her irregular cornea, careful screening 
pre-operatively, while paying special attention to pupil size and ocular history, may help identify patients who are 
at higher risk of developing undesirable outcomes. 
CONCLUSION
Simultaneous T-PRK and CXL can effectively improve corrected and uncorrected visual acuities while slowing 
the progression of PMD and other keratoectasiae.8,10 This combination may effectively delay the need for more 
invasive management such as penetrating keratoplasty and implantation of intrastromal ring segments.17 This case 
report reviewed two significant long-term complications after these procedures (glare associated with persistent 
stromal haze and chronic dryness), which resulted in the patient’s dissatisfaction with the outcome. A more careful 
consideration of inclusion criteria for these procedures may ultimately increase the relative benefits of slowing the 
progression of PMD while decreasing the relative risks of complications.  l 
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